<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During a 5-year period, 85 patients with <z:hpo ids='HP_0002326'>TIAs</z:hpo>, 65 patients with embolic <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> of cardiac source and 50 patients with progressing <z:hpo ids='HP_0001297'>stroke</z:hpo> received intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> within 96 h </plain></SENT>
<SENT sid="1" pm="."><plain>Twelve (6%) developed an early <z:mp ids='MP_0001914'>bleeding</z:mp> in the area involved by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In the 2 cases with <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> (<z:hpo ids='HP_0002326'>TIAs</z:hpo>) (2.3%), major functional sequelae persisted and the 2 cases with emboli from heart (3.2%) died, whereas among the 8 cases with progressing <z:hpo ids='HP_0001297'>stroke</z:hpo> (16%), only 3 worsened from <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>-induced <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001916'>Intracerebral bleeding</z:mp> was not associated with excessive anticoagulation or <z:mp ids='MP_0002842'>high blood pressure</z:mp> and was related to a large infarction only in the cases with emboli from the heart </plain></SENT>
<SENT sid="4" pm="."><plain>Among the 108 patients who were placed on <z:chebi fb="0" ids="53766,53768,53769">acenocoumarol</z:chebi> during 3-12 months after <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy, only one (0.9%) suffered a hemorrhagic <z:mpath ids='MPATH_124'>infarct</z:mpath> from a probable recurrent embolization </plain></SENT>
<SENT sid="5" pm="."><plain>The risk of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>-induced <z:mp ids='MP_0001916'>intracerebral bleeding</z:mp> is quite different between the varieties of preceding ischemic events, with different subsequent impact on prognosis </plain></SENT>
</text></document>